您的购物车当前为空
ALDH1A3-IN-1 (Compound 14) 是有效的 ALDH1A3抑制剂,可用于前列腺癌的研究, (IC50 = 0.63 μM; Ki = 0.46 μM)。


为众多的药物研发团队赋能,
让新药发现更简单!
ALDH1A3-IN-1 (Compound 14) 是有效的 ALDH1A3抑制剂,可用于前列腺癌的研究, (IC50 = 0.63 μM; Ki = 0.46 μM)。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 375 | 5日内发货 | |
| 5 mg | ¥ 825 | 5日内发货 | |
| 10 mg | ¥ 1,250 | 5日内发货 | |
| 25 mg | ¥ 2,490 | 5日内发货 | |
| 50 mg | ¥ 3,950 | 5日内发货 | |
| 100 mg | ¥ 6,470 | 5日内发货 |
ALDH1A3-IN-1 相关产品
| 产品描述 | ALDH1A3-IN-1 (Compound 14) is a potent inhibitor of ALDH1A3 which can be used in prostate cancer research (IC50 = 0.63 μM; Ki = 0.46 μM) [1]. |
| 靶点活性 | ALDH1A1:7.08 μM, ALDH1A3:0.63 μM, ALDH3A1:8.00 μM, ALDH1A3:0.46 μM (Ki), ALDH1A3:26.92 μM (Km) |
| 体外活性 | ALDH1A3-IN-1 (Compound 14) (0-200 μM, 96 h) shows antiproliferative activity in prostate cancer cell lines [1]. ALDH1A3-IN-1 (0-200 μM, 72 h) reduces cell viability of primary prostate cells in a dose-dependent manner [1]. Cell Proliferation Assay [1] Cell Line: PC3, LNCaP, and DU145 cells Concentration: 12.5-200 μM Incubation Time: 96 h Result: Showed antiproliferative activity with IC 50 values of 47 ± 6, 25 ± 1, and 61 ± 5 μM against PC3, LNCaP, and DU145 cells. Cell Viability Assay [1] Cell Line: Primary cells cultured at early passage from human prostate tissue biopsies Concentration: 50 and 200 μM Incubation Time: 72 h Result: Resulted a dose-dependent reduction in percentage cell viability of primary prostate epithelial cultures. |
| 分子量 | 284.19 |
| 分子式 | C13H18BrNO |
| CAS No. | 1695970-90-1 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容